Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
06/1992
06/03/1992CN1061595A Heterocyclic compounds ad antagonists of excitatory amino acid receptors, processes for their preparation and their use
06/03/1992CN1061594A Hydroxyalkylquineline ether acids as leakotaiene antagonists
06/03/1992CN1016872B Bcd tricyclic ergoline part-structure analoguse
06/02/1992US5118806 Enzyme inhibitor for lipoxygenase; useful for treating cancer, hepatic diseases, inflammation, cerebrovascular diseases
06/02/1992US5118701 Antiischemic agents, anticoagulants
06/02/1992US5118694 Benzopyran derivatives
06/02/1992US5118689 Antiarrhythmia agents
06/02/1992US5118687 1-oxa-2-oxo-8-azaspiro(4,5)decane derivatives, pharmaceutical compositions containing them and process for preparing same
06/02/1992US5118686 Phenylpyrimidones
06/02/1992US5118685 Aminopropanol derivatives of substituted 2-hydroxy-propiophenones, and therapeutic agents containing these compounds
06/02/1992US5118682 P-hydroxy phenone derivatives and the use thereof
06/02/1992US5118668 Peptide having sequence of appotinin where in one or more amino acids are replaced at position 15,16,17,18 34-39 and 52. by naturally occuring amino acid useful for hyperfibrinolytic or traumatic hemorrhage
06/02/1992US5118505 Ginkge extract and folic, lipoic and(or) vitamin b
06/02/1992CA1302425C Prodrugs of antihypercholesterolemic compounds
06/02/1992CA1302409C Benzazepine derivatives
06/02/1992CA1302405C Ergoline derivatives
06/02/1992CA1302268C Pharmaceutical compositions containing diltiazem and an enzyme inhibitor
05/1992
05/30/1992CA2056560A1 Guanidine derivates, the process for the preparation thereof and the pharmaceutical compositions containing them
05/30/1992CA2056032A1 Hard capsule preparation
05/29/1992WO1992009582A1 Imidazol-2-yl derivatives of substituted bicyclic compounds and process for their preparation
05/29/1992WO1992008708A1 Biologically active amines
05/29/1992WO1992008694A1 Aminosulfonyl urea acat inhibitors
05/29/1992WO1992008693A1 Aminosulfonyl carbamates
05/29/1992WO1992008692A1 Oxysulfonyl urea acat inhibitors
05/29/1992WO1992008480A1 A β-TYPE TRANSFORMING GROWTH FACTOR
05/29/1992WO1992008473A1 Therapeutic use of fibroblast growth factor
05/29/1992CA2096441A1 Heterodimer of b-type transforming growth factors 2 and 3
05/29/1992CA2094807A1 Aminosulfonyl carbamates
05/29/1992CA2074729A1 Imidazol-2-yl derivatives of substituted bicyclic compounds and process for their preparation
05/27/1992EP0487423A1 Benzoselenazolinone derivatives, their preparation and pharmaceutical compositions containing them
05/27/1992EP0487410A2 Endothelin antagonists
05/27/1992EP0487382A1 Use of buflomedil for the protection of the myocardium by coronary angioplasty
05/27/1992EP0487252A1 Quinoline and 1,5-Naphthyridine derivatives, process and intermediates for their preparation and pharmaceutical compositions containing them
05/27/1992EP0486882A1 Substituted anilides
05/27/1992EP0486809A2 Use of suramin against TNF-related diseases
05/27/1992DE4037941A1 Cyclopentanetherderivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung Cyclopentanetherderivate, processes for their preparation and their pharmaceutical use
05/27/1992DE4037174A1 Neue sulfonamide, verfahren zu ihrer herstellung und arzneimittel, die diese verbindungen enthalten New sulfonamides, process for their production and pharmaceuticals containing these compounds
05/27/1992CN1061413A Pharmaceutical compounds
05/27/1992CN1061410A Substituted azoles, process for their preparation, agents containing them and their use
05/27/1992CN1061407A Unsaturated hydroxyalkylquinoline acids as leukotriene antagonists
05/27/1992CA2054638A1 Benzodiazolo analogs
05/26/1992US5116986 Heteroaromatic amine derivatives
05/26/1992US5116974 3-carbalkoxyamino-5-aminoacyl-5H-dibenz[b,f]azepines, and methods for making
05/26/1992US5116964 Hybrid immunoglobulins
05/26/1992US5116878 Medicinal composition for the treatment and prevention of the symptoms of heart failure, containing a vasoconstrictor alpha-stimulant agent as active principle
05/26/1992US5116871 Fatty acid therapy and compositions for the treatment of myalgic encephalomyelitis
05/26/1992US5116856 Aminoethylthiazole and aminoethyloxazole derivatives
05/26/1992US5116851 Pharmaceutical composition and method for treating cardiovascular diseases using substituted anilides and sulfonamides
05/26/1992US5116849 4-amidino chroman and 4-amidino pyrano (3,2-c) pyridine derivatives, a process for their preparation and pharmaceutical compositions containing them
05/26/1992US5116848 N-(((2,6-disubstituted)phenyl)-n-diarylalkyl)ureas as antihyperlipidemic and antiatherosclerotic agents
05/26/1992US5116837 2,9-dihydro-(6 or 7)-(3-oxo-2,3,4,5-tetrahydropyridazinyl)-pyrazolo [4,3-B]-1,4-benzoxazines
05/26/1992US5116835 Enzyme-inhibiting urea derivatives of dipeptides, a process for the preparation thereof, agents containing these, and the use thereof
05/26/1992US5116617 Pharmaceutical composition for topical use in the treatment of the capillary fragility
05/26/1992CA1302005C Aminoacid derivatives as antihypertensives
05/26/1992CA1301770C Isothiuronium salts
05/26/1992CA1301759C Pyranopyridines having antihypertensive activity
05/26/1992CA1301652C Continuous intravenous infusion of adenosine to human patients
05/25/1992CA2056063A1 Aminodiol derivatives
05/24/1992WO1992009573A2 Cyclopentane ether derivatives, methods for preparing them and their use in pharmaceuticals
05/24/1992CA2096848A1 Cyclopentane ether derivatives, methods for preparing them and their use in pharmaceuticals
05/24/1992CA2056008A1 Benzoselenazolinone derivatives; process for preparing the same and pharmaceutical compositions containing them
05/23/1992WO1992009571A1 Medicaments containing sulphonamides, novel sulphonamides and proces for producing them
05/23/1992CA2096847A1 Pharmaceutical preparations containing sulfonamides novel sulfonamides and processes for their production
05/22/1992WO1992009556A1 Improved matrix metalloprotease inhibitors
05/22/1992CA2096221A1 Matrix metalloprotease inhibitors
05/22/1992CA2055902A1 Peptide derivatives, their preparation process, application of these new derivatives as drugs and pharmaceutical compositions containing them
05/20/1992EP0486478A2 Renin-inhibiting peptides
05/20/1992EP0486386A2 Novel derivatives of N-benzoylproline, process for their preparation and drugs containing them
05/20/1992EP0486385A1 Imidazole derivatives, process for their fabrication and pharmaceutical compositions containing them
05/20/1992EP0486001A1 Recombinant urinary trypsin inhibitor fragments and drug composition
05/20/1992EP0485962A2 New tricyclic compounds
05/20/1992EP0485961A1 Oncostatin M for stimulating LDL uptake and LDL receptor expression
05/20/1992EP0485929A1 Substituted azoles, process for their preparation and their application
05/20/1992EP0485748A2 Salts of glycosaminoglycans with esters of aminoacids, preparation thereof and pharmaceutical formulations containing them
05/20/1992EP0485476A1 Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof
05/20/1992CN1061224A Indole-and benzimidazole-substitued imidazole and benzimidazole derivatives
05/20/1992CN1061152A Ester inhibitors
05/20/1992CA2054555A1 Nitrogen compounds
05/19/1992US5114966 2,3-dihydro-5-oxy-4,6,7-trimethylbenzofurans 2-(rs)-substituted, useful as antioxidizing pharmaceutical products having mucoregulating and anti-ischemic properties
05/19/1992US5114952 Isoquinolinylsulfonamides as anti-arrhythmic agents
05/19/1992US5114941 Pyrimidinedione derivative compounds, method for preparing same, and antiarrythmic agents containing same
05/19/1992US5114927 Hypotensive agents and inhibiting renin
05/19/1992US5114916 Therapeutic agent for the prevention of intraventricular hemorrhage in premature infants
05/19/1992CA1301183C2 Aralykyl (arylethynyl) aralkyl amines and their use as vasodilators and antihypertensives
05/19/1992CA1301174C Substituted 1h-imidazoles
05/19/1992CA1301171C 1,12b-disubstituted octahydroindolo ¬2,3-a| quinolizine derivatives, process for their preparation and pharmaceutical compositions containing them
05/18/1992CA2055689A1 Substituted anilides
05/17/1992CA2055680A1 Tricyclic compounds
05/17/1992CA2055636A1 Substituted azoles, process for their preparation, agents containing them and their use
05/16/1992WO1992008724A1 New heterocyclic compounds as antagonists of excitatory amino acid receptors, processes for their preparation and their use
05/16/1992WO1992008453A1 Hydroxamic acids for preventing reperfusion injury
05/16/1992CA2095606A1 Hydroxamic acids for preventing reperfusion injury
05/16/1992CA2095224A1 Heterocyclic compounds as antagonists of excitatory amino acid receptors, processes for their preparation and their use
05/15/1992WO1992008705A1 5-fluoro-2,4,6-pyrimidinetriamine compounds
05/15/1992WO1992008482A1 Compositions for reducing oxidative injury
05/15/1992CA2096333A1 Compositions for reducing oxidative injury
05/15/1992CA2092811A1 5-fluoro-2,4,6-pyrimidinetriamine compounds
05/15/1992CA2055326A1 N-benzoylproline derivatives, a process for their preparation and pharmaceutical compositions holding same
05/15/1992CA2055325A1 Novel imidazole derivatives, process for preparing them and pharmaceutical compositions containing them
05/14/1992WO1992007937A1 Polypeptides having human dopaminergic receptor activity, nucleic acids coding for said polypeptides and uses thereof for screening active substances on said polypeptides